Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2003
11/20/2003WO2003030836A3 Neuronal regeneration
11/20/2003WO2003024357A3 Microfabricated nanopore device for sustained release of therapeutic agent
11/20/2003WO2003023004A3 Antisense modulation of fibroblast growth factor receptor 3 expression
11/20/2003WO2003022998A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/20/2003WO2003020764A3 Modified factor ix
11/20/2003WO2003019136A3 Methods for inhibiting angiogenesis
11/20/2003WO2003016506A3 Secreted proteins
11/20/2003WO2003016331A3 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy
11/20/2003WO2003012093A3 Regulator of calcineurin
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003004613A3 Novel pgc-1 isoforms and uses therefor
11/20/2003WO2003004088A3 Method of administration of a gene of interest to the heart and vasculature
11/20/2003WO2003002601A3 AFXz TRANSCRIPTION FACTOR SPLICE FORM
11/20/2003WO2003000891A3 Protein-protein interactions in the inner ear
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2003000021A3 Pancam nucleic acids and polypeptides
11/20/2003WO2002103026A3 Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments
11/20/2003WO2002101045A3 Vanilloid receptor-related nucleic acids and polypeptides
11/20/2003WO2002099116A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/20/2003WO2002098915A3 Compositions and methods for detecting or regulating cholesteryl ester transfer protein
11/20/2003WO2002096944A3 New heterotetrameric potassium channels and uses thereof
11/20/2003WO2002095011A3 Inactivation of genes of the mep pathway
11/20/2003WO2002094775A3 Recombinant simian gpr3 receptor
11/20/2003WO2002090544A3 Protein-protein interactions in adipocyte cells (3)
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002088380A3 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
11/20/2003WO2002088181A3 Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
11/20/2003WO2002086071A3 Cancer-testis antigens
11/20/2003WO2002085310A3 Antibiotics aa-896
11/20/2003WO2002085287A3 Minimal adenoviral vectors for immunization
11/20/2003WO2002083736A3 G-protein coupled receptor molecules and uses thereof
11/20/2003WO2002081642A3 Gene brcc-3 and diagnostic and therapeutic uses thereof
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002077235A3 Intracellular signaling molecules
11/20/2003WO2002077234A3 Compositions and methods relating to colon specific genes and proteins
11/20/2003WO2002072825A3 Human mrp5-like protein
11/20/2003WO2002072807A3 Chimeric metal-binding peptides with nuclease activity
11/20/2003WO2002072146A3 Combination of nateglinide or repaglinide with at least one further antidiabetic compound
11/20/2003WO2002070698A3 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity
11/20/2003WO2002069906A3 Compounds and methods for the treatment of urogenital disorders
11/20/2003WO2002066048A8 Crystal modification of a cyclic depsipeptide having improved strength
11/20/2003WO2002064734A3 Identification of target-specific folding sites in peptides and proteins
11/20/2003WO2002062368A8 Method of inducing a ctl response
11/20/2003WO2002060935A3 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
11/20/2003WO2002058731A3 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
11/20/2003WO2002057408A8 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
11/20/2003WO2002055547A3 Sfrp and peptide motifs that interact with sfrp and methods of their use
11/20/2003WO2002053092A8 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis
11/20/2003WO2002046767A3 Diagnosis and treatment of alzheimer's disease
11/20/2003WO2002044417A9 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
11/20/2003WO2002041910A3 Methods and compositions for the treatment of diseases of the eye
11/20/2003WO2002038744A3 Proteases
11/20/2003WO2002036624A9 Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof
11/20/2003WO2002034915A3 Preferred segments of neural thread protein and methods of using the same
11/20/2003WO2002033050A8 Methods and compositions for promoting the maturation of monocytes
11/20/2003WO2002016407A3 Sh2 domain binding inhibitors
11/20/2003WO2002008765A3 Basal cell markers in breast cancer and uses thereof
11/20/2003WO2001091700A8 Composition and method for enhancing elasticity of tissue
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003US20030217377 Oligonucleotide-directed repair or alteration of genetic information
11/20/2003US20030217375 Transgenic animals expressing heparanase and uses thereof
11/20/2003US20030216811 Vascularization enhanced graft constructs
11/20/2003US20030216575 Novel pyranosyl cytosines: pharmaceutical formulations and methods
11/20/2003US20030216574 Pyrazine based inhibitors of glycogen synthase kinase 3
11/20/2003US20030216562 Genetic engineered polypeptides; binding to antibodies; recovering culture product
11/20/2003US20030216561 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216560 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216552 Comprises monoclonal antibody capable of binding cytokine for treating tumors; compeptive binding
11/20/2003US20030216549 Comprises modified chemokine for use as antiinflammatory, viricidal or antiallergenic agent
11/20/2003US20030216548 Sp110, a polypeptide component of the nuclear body
11/20/2003US20030216547 Comprises hexadecapeptide for diagnosis and treatment of nervous system disorders
11/20/2003US20030216546 Genetically engineered fusion proteins for use in diagnosis and treatment of cancer, viral infections, autoimmune and alloimmune diseases
11/20/2003US20030216545 Comprises nucleotide sequences coding g-protein coupled receptors for diagnosing and treating cancer
11/20/2003US20030216544 Methods and reagents for diagnosis of autoantibodies
11/20/2003US20030216542 Modified insulin for delivery to lungs by breathing and treatment of diabetes
11/20/2003US20030216541 Systemic administration of a therapeutic preparation
11/20/2003US20030216466 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
11/20/2003US20030216435 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216391 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
11/20/2003US20030216352 Multicomponent complex for use with a substrate
11/20/2003US20030216345 Apoptosis inducer and anticancer agent, especially an antisense oligonucleotide
11/20/2003US20030216344 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/20/2003US20030216343 Expression vectors for stimulating an immune response and methods of using the same
11/20/2003US20030216342 Expression vectors for stimulating an immune response and methods of using the same
11/20/2003US20030216336 Suppression of nuclear factor-kappaB dependent processes using oligonucleotides
11/20/2003US20030216335 Treating endometriosis by contacting the subject with a nucleic acid that modulates the expression of VEGF, VEGFR1, and/or VEGFR2
11/20/2003US20030216333 Antisense modulation of glycogen synthase kinase3 alpha expression
11/20/2003US20030216325 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
11/20/2003US20030216323 Ku-70-derived Bax-suppressing peptides and use thereof for the protection of damaged cells
11/20/2003US20030216322 Containing the motif E(L/V/S)RGDS
11/20/2003US20030216321 Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof
11/20/2003US20030216319 Selective suppression of autoimmune activity against an auto-antigen
11/20/2003US20030216317 Protein having cell-recognizing activity and/or cytocidal activity
11/20/2003US20030216316 Pharmaceutical compositions comprising erythropoietin for treatment of cancer
11/20/2003US20030216315 Modulation of immune response by non-peptide binding stress response polypeptides
11/20/2003US20030216312 Administering a bactericidal/permeability-increasing (BPI) protein product
11/20/2003US20030216310 Expression vectors, host cells, antibodies, agonists, and antagonists.
11/20/2003US20030216309 Binding peptides specific for the extracellular domain of ErbB2 and uses therefor
11/20/2003US20030216308 NOVX polynucleotides and polypeptides utilized in the detection and treatment of a broad range of pathological states
1 ... 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 ... 3163